BRIACELL THERAPEUTICS CORP. Deferred Tax Assets, Operating Loss Carryforwards
BRIACELL THERAPEUTICS CORP. (BCTX) had Deferred Tax Assets, Operating Loss Carryforwards of $8.49 million as of 2025-07-31, per its 10-K filed 2025-10-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-10-16
- 2025-07-31: Deferred Tax Assets, Operating Loss Carryforwards $8.49M.
- 2024-07-31: Deferred Tax Assets, Operating Loss Carryforwards $5.55M.
- 2023-07-31: Deferred Tax Assets, Operating Loss Carryforwards $4.91M.
- 2022-07-31: Deferred Tax Assets, Operating Loss Carryforwards $4.02M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-07-31 | $8.49M 10-K · filed 2025-10-16 |
| 2024-07-31 | $5.55M 10-K · filed 2025-10-16 |
| 2023-07-31 | $4.91M 10-K · filed 2024-10-29 |
| 2022-07-31 | $4.02M 10-K · filed 2023-10-25 |
| 2021-07-31 | $3.91M 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |